Immune regulation in T1D and T2D: Prospective role of Foxp3+ treg cells in disease pathogenesis and treatment

Frontiers in Endocrinology

Volumn 4, Issue JUN, 2013, Pages

  Kornete, Mara ^a,b   Mason, Edward S ^a,b   Piccirillo, Ciriaco A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Diabetes; Foxp3; Immune regulation; Inflammation; Metabolic; Obesity; Treg

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; INSULIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; OTELIXIZUMAB; STRESS ACTIVATED PROTEIN KINASE; TEPLIZUMAB; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; VACCINE;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; AUTOIMMUNITY; BLINDNESS; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL REGENERATION; CLINICAL TRIAL (TOPIC); DIABETIC NEPHROPATHY; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 84884181617     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00076     Document Type: Review

References (80)

1. Abdul-Rasoul, M., Habib, H., and Al-Khouly, M. (2006). The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr. Diabetes 7, 101-107. doi:10.1111/j.1399-543X.2006.00155.x
2. Ablamunits, V., Sherry, N. A., Kushner, J. A., and Herold, K. C. (2007). Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann. N. Y. Acad. Sci. 1103, 19-32. doi:10.1196/annals.1394.006
3. Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A. K., Gourdy, P., Zoll, J., et al. (2006). Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180. doi:10.1038/nm1343
4. Akirav, E., Kushner, J. A., and Herold, K. C. (2008). Beta-cell mass and type 1 diabetes: going, going, gone? Diabetes 57, 2883-2888. doi:10.2337/db07-1817
5. Anderson, M. S., and Bluestone, J. A. (2005). The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23, 447-485. doi:10.1146/annurev.immunol.23.021704.115643
6. Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, A., Li, Z. W., Long, J. M., et al. (2005). IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191-198. doi:10.1038/nm1185
7. Atkinson, M. A., and Leiter, E. H. (1999). The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5, 601-604. doi:10.1038/9442
8. Bach, J. F., and Chatenoud, L. (2001). Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131-161. doi:10.1146/annurev.immunol.19.1.131
9. Berg, A. K., Korsgren, O., and Frisk, G. (2006). Induction of the chemokine interferon-gamma-inducible protein-10 in human pancreatic islets during enterovirus infection. Diabetologia 49, 2697-2703. doi:10.1007/s00125-006-0429-7
10. Bruun, J. M., Verdich, C., Toubro, S., Astrup, A., and Richelsen, B. (2003). Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur. J. Endocrinol. 148, 535-542. doi:10.1530/eje.0.1480535
11. 3+ regulatory T cells. Nat. Rev. Immunol. 11, 119-130. doi:10.1038/nri2916
12. 3 monoclonal antibody. Eur. J. Immunol. 12, 979-982. doi:10.1002/eji.1830121116
13. 3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 91, 123-127. doi:10.1073/pnas.91.1.123
14. Chervonsky, A. V. (2010). Influence of microbial environment on autoimmunity. Nat. Immunol. 11, 28-35. doi:10.1038/ni.1801
15. 9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171, 6838-6845.
16. Chung, C. H., Hao, E., Piran, R., Keinan, E., and Levine, F. (2010). Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Stem Cells 28, 1630 -1638. doi:10.1002/stem.482
17. Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., et al. (2012). PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549-553. doi:10.1038/nature11132
18. de Boer, O. J., Van Der Meer, J. J., Teeling, P., Van Der Loos, C. M., and Van Der Wal, A. C. (2007). Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2:e779. doi:10.1371/journal.pone.0000779
19. d'Hennezel, E., Bin Dhuban, K., Torgerson, T., and Piccirillo, C. A. (2012). The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 49, 291-302. doi:10.1136/jmedgenet-2012-100759
20. Donath, M. Y., Storling, J., Maedler, K., and Mandrup-Poulsen, T. (2003). Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J. Mol. Med. (Berl.) 81, 455-470. doi:10.1007/s00109-003-0450-y
21. Dor, Y., Brown, J., Martinez, O. I., and Melton, D. A. (2004). Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41-46. doi:10.1038/nature02520
22. Eller, K., Kirsch, A., Wolf, A. M., Sopper, S., Tagwerker, A., Stanzl, U., et al. (2011). Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 60, 2954-2962. doi:10.2337/db11-0358
23. Fernandes, A., King, L. C., Guz, Y., Stein, R., Wright, C. V., and Teitelman, G. (1997). Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology 138, 1750-1762. doi:10.1210/en.138.4.1750
24. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., et al. (2009). Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939. doi:10.1038/nm.2002
25. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., and Rudensky, A. Y. (2005). A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151. doi:10.1038/ni1263
26. Galkina, E., and Ley, K. (2006). Leukocyte recruitment and vascular injury in diabetic nephropathy. J. Am. Soc. Nephrol. 17, 368-377. doi:10.1681/ASN.2005080859
27. Grinberg-Bleyer, Y., Baeyens, A., You, S., Elhage, R., Fourcade, G., Gregoire, S., et al. (2010). IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207, 1871-1878. doi:10.1084/jem.20100209
28. Guz, Y., Nasir, I., and Teitelman, G. (2001). Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 142, 4956-4968. doi:10.1210/en.142.11.4956
29. Haiqi, H., Yong, Z., and Yi, L. (2011). Transcriptional regulation of Foxp3 in regulatory T cells. Immunobiology 216, 678-685. doi:10.1016/j.imbio.2010.11.002
30. 3 mAb Teplizumab preserves insulin production for up to 5 years. Clin. Immunol. 132, 166-173. doi:10.1016/j.clim.2009.04.007
31. 3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698. doi:10.1056/NEJMoa012864
32. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061. doi:10.1126/science.1079490
33. Kaufman, D. L., Erlander, M. G., Clare-Salzler, M., Atkinson, M. A., Maclaren, N. K., and Tobin, A. J. (1992). Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89, 283-292. doi:10.1172/JCI115573
34. 3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352, 2598-2608. doi:10.1056/NEJMoa043980
35. Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G. N., Strodthoff, D., Rudling, M., et al. (2010). Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 946-952. doi:10.1161/ATVBAHA.109.202671
36. Knip, M., Veijola, R., Virtanen, S. M., Hyoty, H., Vaarala, O., and Akerblom, H. K. (2005). Environmental triggers and determinants of type 1 diabetes. Diabetes 54 (Suppl. 2), S125-S136. doi:10.2337/diabetes.54.suppl_2.S125
37. 3+ regulatory T cells in islets of nonobese diabetic mice. J. Immunol. 188, 1064-1074. doi:10.4049/jimmunol.1101303
38. Krishnamurthy, B., Dudek, N. L., Mckenzie, M. D., Purcell, A. W., Brooks, A. G., Gellert, S., et al. (2006). Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116, 3258-3265. doi:10.1172/JCI29602
39. 25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 59, 407-415. doi:10.2337/db09-0694
40. Ludvigsson, J., Faresjo, M., Hjorth, M., Axelsson, S., Cheramy, M., Pihl, M., et al. (2008). GAD treatment and insulin secretion in recent-onset type 1 diabetes. N. Engl. J. Med. 359, 1909-1920. doi:10.1056/NEJMoa0804328
41. Lumeng, C. N., Bodzin, J. L., and Saltiel, A. R. (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184. doi:10.1172/JCI29881
42. 3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation 79, 1091-1096. doi:10.1097/01.TP.0000161223.54452.A2
43. Lyons, P. A., Armitage, N., Argentina, F., Denny, P., Hill, N. J., Lord, C. J., et al. (2000). Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 10, 446-453. doi:10.1101/gr.10.4.446
44. Mallat, Z., Gojova, A., Brun, V., Esposito, B., Fournier, N., Cottrez, F., et al. (2003). Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108, 1232-1237. doi:10.1161/01.CIR.0000089083.61317.A1
45. Mathis, D., and Benoist, C. (2012). The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol. Rev. 245, 239-249. doi:10.1111/j.1600-065X.2011.01084.x
46. McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., et al. (2011). Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918-3926. doi:10.4049/jimmunol.1003099
47. Moon, J. Y., Jeong, K. H., Lee, T. W., Ihm, C. G., Lim, S. J., and Lee, S. H. (2012). Aberrant recruitment and activation of T cells in diabetic nephropathy. Am. J. Nephrol. 35, 164-174. doi:10.1159/000334928
48. Muhammad, B. J., Swift, P. G. F., Raymond, N. T., and Botha, J. L. (1999). Partial remission phase of diabetes in children younger than age 10 years. Arch. Dis. Child. 80, 367-369. doi:10.1136/adc.80.4.367
49. Nir, T., Melton, D. A., and Dor, Y. (2007). Recovery from diabetes in mice by beta cell regeneration. J. Clin. Invest. 117, 2553-2561. doi:10.1172/JCI32959
50. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., et al. (2009). CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914-920. doi:10.1038/nm.1964
51. Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., et al. (2009). Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 32, 2269-2274. doi:10.2337/dc09-0934
52. 3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells. J. Immunol. 187, 2015-2022. doi:10.4049/jimmunol.1100713
53. Piccirillo, C. A., Tritt, M., Sgouroudis, E., Albanese, A., Pyzik, M., and Hay, V. (2005). Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Ann. N. Y. Acad. Sci. 1051, 72-87. doi:10.1196/annals.1361.048
54. Rooman, I., Lardon, J., and Bouwens, L. (2002). Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51, 686-690. doi:10.2337/diabetes.51.3.686
55. Sabbah, E., Savola, K., Kulmala, P., Veijola, R., Vahasalo, P., Karjalainen, J., et al. (1999). Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes in Finland Study Group. J. Clin. Endocrinol. Metab. 84, 1534-1539. doi:10.1210/jc.84.5.1534
56. Sabio, G., Kennedy, N. J., Cavanagh-Kyros, J., Jung, D. Y., Ko, H. J., Ong, H., et al. (2010). Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol. Cell. Biol. 30, 106-115. doi:10.1128/MCB.01162-09
57. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P., and Yamaguchi, T. (2009). Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105-1111. doi:10.1093/intimm/dxp095
58. Salomon, B., and Bluestone, J. A. (2001). Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252. doi:10.1146/annurev.immunol.19.1.225
59. Salomon, B. T., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., et al. (2000). B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440. doi:10.1016/S1074-7613(00)80195-8
60. 3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice. J. Immunol. 181, 6283-6292.
61. Shen, Z., Chen, L., Hao, F., and Wu, J. (2009). Transcriptional regulation of Foxp3 gene: multiple signal pathways on the road. Med. Res. Rev. 29, 742-766. doi:10.1002/med.20152
62. Sherry, N. A., Kushner, J. A., Glandt, M., Kitamura, T., Brillantes, A. M., and Herold, K. C. (2006). Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55, 3238-3245. doi:10.2337/db05-1034
63. 3+ T regulatory cell-mediated suppression. Immunity 30, 636-645. doi:10.1016/j.immuni
64. Skyler, J. S., Krischer, J. P., Wolfsdorf, J., Cowie, C., Palmer, J. P., Greenbaum, C., et al. (2005). Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial - Type 1. Diabetes Care 28, 1068-1076. doi:10.2337/diacare.28.5.1068
65. 3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 114, 1977-1984. doi:10.1161/CIRCULATIONAHA.106.627430
66. Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., et al. (2008). Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687-697. doi:10.1016/j.immuni.2008.03.016
67. Thorel, F., Nepote, V., Avril, I., Kohno, K., Desgraz, R., Chera, S., et al. (2010). Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464, 1149-1154. doi:10.1038/nature08894
68. Thyssen, S., Arany, E., and Hill, D. J. (2006). Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin. Endocrinology 147, 2346 -2356. doi:10.1210/en.2005-0396
69. Tritt, M., Sgouroudis, E., d'Hennezel, E., Albanese, A., and Piccirizllo, C. A. (2008). Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 57, 113-123. doi:10.2337/db06-1700
70. Tuch, B. E., Simpson, A. M., and Campbell, I. L. (1991). Role of tumor necrosis factor-alpha and interferon-gamma as growth factors to the human fetal beta-cell. J. Clin. Endocrinol. Metab. 73, 1044-1050. doi:10.1210/jcem-73-5-1044
71. van Puijvelde, G. H., Hauer, A. D., De Vos, P., Van Den Heuvel, R., Van Herwijnen, M. J., Van Der Zee, R., et al. (2006). Induction of oral tolerance to oxidized lowdensity lipoprotein ameliorates atherosclerosis. Circulation 114, 1968-1976. doi:10.1161/CIRCULATIONAHA.106.615609
72. Veillard, N. R., Steffens, S., Burger, F., Pelli, G., and Mach, F. (2004). Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice. Arterioscler. Thromb. Vasc. Biol. 24, 2339-2344. doi:10.1161/01.ATV.0000146532.98235.e6
73. Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H., and Harris, T. B. (1999). Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131-2135. doi:10.1001/jama.282.22.2131
74. Weisberg, S. P., Mccann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W. Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808. doi:10.1172/JCI19246
75. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., et al. (2009). Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921-929. doi:10.1038/nm.2001
76. 3 antibody treatment. Proc. Natl. Acad. Sci. U.S.A. 104, 6335-6340. doi:10.1073/pnas.0701171104
77. Zaret, K. S., and White, M. F. (2010). Diabetes forum: extreme makeover of pancreatic alpha-cells. Nature 464, 1132-1133. doi:10.1038/4641132a
78. Zeyda, M., Farmer, D., Todoric, J., Aszmann, O., Speiser, M., Gyori, G., et al. (2007). Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes. (Lond.) 31, 1420-1428. doi:10.1038/sj.ijo.0803632
79. Zeyda, M., Huber, J., Prager, G., and Stulnig, T. M. (2011). Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients. Obesity (Silver Spring) 19, 743-748. doi:10.1038/oby.2010.123
80. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., et al. (2009). Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007. doi:10.1038/ni.1774